CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 47  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0914
LYS 10.0451
GLU 20.0238
LEU 30.0395
ARG 40.0467
CYS 50.0206
GLN 60.0136
CYS 70.0300
ILE 80.0312
LYS 90.0020
THR 100.0220
TYR 110.0341
SER 120.0507
LYS 130.0365
PRO 140.0075
PHE 150.0340
HIS 160.0914
PRO 170.0223
LYS 180.0264
PHE 190.0287
ILE 200.0142
LYS 210.0151
GLU 220.0132
LEU 230.0077
ARG 240.0133
VAL 250.0148
ILE 260.0136
GLU 270.0331
SER 280.0160
GLY 290.0567
PRO 300.0515
HIS 310.0313
CYS 320.0285
ALA 330.0423
ASN 340.0363
THR 350.0360
GLU 360.0182
ILE 370.0147
ILE 380.0143
VAL 390.0069
LYS 400.0145
LEU 410.0108
SER 420.0188
ASP 430.0166
GLY 440.0159
ARG 450.0074
GLU 460.0082
LEU 470.0066
CYS 480.0129
LEU 490.0107
ASP 500.0158
PRO 510.0160
LYS 520.0196
GLU 530.0118
ASN 540.0197
TRP 550.0177
VAL 560.0114
GLN 570.0154
ARG 580.0156
VAL 590.0044
VAL 600.0078
GLU 610.0106
LYS 620.0090
PHE 630.0088
LEU 640.0141
LYS 650.0156
ARG 660.0089
ALA 670.0167
GLU 680.0184
ASN 690.0267

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.